Skip to main content
. 2015 Feb 9;2(1):e000018. doi: 10.1136/bmjgast-2014-000018

Table 2.

Comparison of efficacies of VSL#3 and mesalamine at 8 weeks

Parameter Group A (n=11) Group B (n=13) p Value 95% CI
Stool frequency (mean±SD; number of bowel movements/day) 2.36±1.02 2.8±1.2 0.31 −1.46 to 0.49
Stool weight (mean±SD; g) 377.6±104.5 507±168.2 0.03 −248.8 to −10.5
Stool consistency (mean±SD)* 3.45±0.82 3.30±0.48 0.60 −0.45 to 0.74
Diarrhoeal rate (mean±SD)† 0.81±0.40 1.15±0.55 0.10 −0.74 to 0.07
Abdominal pain (mean±SD)‡ 0.5±1.0 0.46±0.66 0.81 0.73 to 0.92
Stool mucus (mean±SD)‡ 1.2±0.7 1.9±0.75 0.03 −1.4 to −0.04
Well-being (mean±SD)§ 2.4±0.5 2.9±0.75 0.06 −1.07 to 0.03

*Likert scale, 1: very hard; 2: hard; 3: formed; 4: loose; 5: watery.

†0: Normal stools, no diarrhoea; 1: up to 4 loose stools per day above normal, 2: 5–7 loose stools per day above normal, 3: >7 loose stools per day above normal.

‡Likert scale, 0: none; 1: mild; 2: moderate; 3: severe.

§Visual analogue scale, 1–5; lower score signifies better well-being.